US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jul 2, 2013 (13 years ago)

NICOTINE POLACRILEX Lozenge

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Label Mixup; NICOTINE POLACRILEX Lozenge, 2 mg may be potentially mislabeled as VITAMIN B COMPLEX WITH C/FOLIC ACID, Tablet, NDC 60258016001, Pedigree: W003361, EXP: 6/19/2014.

What was recalled

NICOTINE POLACRILEX Lozenge, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 49348085216

Recalling firm
Aidapak Services, LLC
Origin
WA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-584-2014

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Nicotine recalls

See all
Class III · Low risk Ongoing

Nicotine Transdermal System Patch

Reason Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.

AVEVA Drug Delivery Systems, Inc. NDC 0536-5895-88 D-0550-2026
Class III · Low risk Terminated

Nicotine Gum

Reason Labeling: Incorrect or Missing Package Insert: The package insert included in the finished product is for the Canadian market and is not part of the current approved drug labeling.

P & L Developments, LLC NDC 11822-3328-3 D-0004-2021
Class III · Low risk Terminated

Nicotine Polacrilex Lozenge

Reason Failed Dissolution Specifications and Failed Tablet Specifications: High 30 minute dissolution test and presence of broken lozenges.

Perrigo Holland Inc D-1558-2014
Class III · Low risk Terminated

Nicorette Lozenge and NicoDerm CQ

Reason Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.

GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline D-1247-2014
Class III · Low risk Terminated

Nicorette

Reason Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.

GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline D-1246-2014